Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Terry Stone

Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

As parts of the nation begin to re-open, new considerations are unfolding that leaders struggle to manage.

Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Businesses must prepare now for the long haul of COVID-19 suppression if they are to survive in a changed economy.

Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Partner and Co-Lead of Digital Transformation, EMEA, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

41% of founders and co-founders at this year’s StartUp Health festival were female. Here’s why this matters for (both female and male) healthcare leaders.

Editor, Health and Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

The Illusions and Temptations of Successful M&A

What we can learn from industries beyond healthcare where M&A activities have generated greater returns.

Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Men hold most (87 percent) of C-suite roles at healthcare’s top ranks. But why?

Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

What over 70 women leaders, from those moving up the ladder to those at its peak, said about their identity.

Director, Strategy & Corporate Development, Landmark Health
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

Oliver Wyman's research findings on diversity in healthcare leadership (some of which surprised us).

Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Director, Strategy & Corporate Development, Landmark Health
Principal, Oliver Wyman
Consultant

An executive conversation on why workplace inclusion is an outcome to strive for.

President and CEO, Florida Blue
Former CEO, Health Evolution
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

Diversity as a Strategic Priority

How can your I&D goals thrive? Walk the talk, says Florida Blue's CEO.

President and CEO, Florida Blue
Former CEO, Health Evolution
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

2018 was a big year for industry news. Here's what might happen next in artificial intelligence, the 2020 presidential election, pharma, and more.

Partner, Health and Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

Insights in your inbox

Subscribe